Comment from Microbial Biotechnology Policy Committee

Summary: The Microbial Biotechnology Policy Committee (MBPC), a task force of companies developing microbial products, supports APHIS's efforts to modernize the regulatory framework for genetically engineered (GE) organisms. They argue for a risk-based, science-driven approach that reduces regulatory barriers, eliminates redundancies between agencies, and provides a predictable pathway for commercializing innovative microbial products.